Patent · US Active

Treatment of gestational diabetes

US7452858B2 · kind B2 · utility

42Cited by
12References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 2005
Grant dateNov 18, 2008
Priority date—
Expiry dateAug 31, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating gestational diabetes which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that lower blood glucose levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.